On May 16, 2019, President Trump signed Proclamation 9761 to remove India from the Generalized System of Preferences, a trade program that has provided duty-free market access to developing nations since 1974. The proclamation eliminated tariff exemptions on roughly 2,000 product categories, effective June 5, 2019. This action was taken unilaterally under the president's authority granted by the Trade Act of 1974, requiring no congressional approval. The removal affected Indian exporters across pharmaceuticals, chemicals, textiles, and agricultural products—sectors where Indian suppliers held significant market share in the United States.
The immediate impact fell on multiple stakeholders. Indian exporters faced sudden tariff obligations on goods previously entering duty-free, forcing them to absorb costs or raise prices. American importers and businesses dependent on Indian supply chains confronted higher procurement costs. Consumers felt secondary effects through elevated prices on medications, textiles, and other imported goods, while U.S. retailers managing inventory from Indian suppliers faced margin pressures. The action particularly affected generic pharmaceutical imports, where Indian manufacturers supply a substantial portion of the U.S. market.
This move fit within a broader pattern of Trump administration trade restrictions that escalated throughout the period. The removal of India's GSP status preceded later actions like the temporary import surcharges and suspension of de minimis duty-free treatment implemented in February 2026, all aimed at rebalancing trade relationships through unilateral executive authority. The administration framed these actions within its declared national emergency on trade deficits, which continued through March 2026. Each action systematically narrowed preferential trade arrangements and expanded tariff collection mechanisms.
No major legal challenges emerged to overturn the proclamation itself, as courts historically grant presidents broad authority over trade policy under existing statutes. However, the cumulative effect of successive tariff actions drew criticism from business groups and trading partners. India sought negotiations for reinstatement but gained limited concessions through diplomatic channels alone.
Removed India from Generalized System of Preferences beneficiary list
💰 Economy · First Term (2017–2021) · 🤖 AI-categorized
On May 16, 2019, President Trump signed Proclamation 9761 removing India from the list of beneficiary developing countries under the Generalized System of Preferences (GSP) program established by the Trade Act of 1974. The proclamation eliminated India's duty-free access to U.S. markets for approximately 2,000 product categories, effective June 5, 2019. Indian exporters faced tariffs on products previously entering the U.S. duty-free, affecting American importers and consumers of goods including pharmaceuticals, chemicals, and textiles.